On December 1, 2017, Hangzhou Centech Medical Management Co., Ltd. and Korea DIAMESCO Group signed a cooperation framework agreement for smart insulin syringes, aiming to promote cooperation between the two parties and promote the use of their products in the Chinese market. This also marks the launch of a smart medical project that integrates mobile wearable devices + Internet interaction + big data...
Compared to other insulin injection pens on the market, this smart insulin pen is intelligent, automated and highly precise. First of all, it can be connected with the mobile phone APP, intelligently set up and operate, save the operation record of injecting insulin, and secondly, it can automatically inject by setting the injection amount in advance, and ensure that each injection can be accurate to 0.1U, its Operationality provides a more convenient injection for diabetics. This is a smart healthcare project that combines mobile wearables + Internet interaction + big data.